BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

398 related articles for article (PubMed ID: 29105486)

  • 1. Can imaging kinetic parameters of dynamic contrast-enhanced magnetic resonance imaging be valuable in predicting clinicopathological prognostic factors of invasive breast cancer?
    Wang C; Wei W; Santiago L; Whitman G; Dogan B
    Acta Radiol; 2018 Jul; 59(7):813-821. PubMed ID: 29105486
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differentiation between subcentimeter carcinomas and benign lesions using kinetic parameters derived from ultrafast dynamic contrast-enhanced breast MRI.
    Onishi N; Sadinski M; Gibbs P; Gallagher KM; Hughes MC; Ko ES; Dashevsky BZ; Shanbhag DD; Fung MM; Hunt TM; Martinez DF; Shukla-Dave A; Morris EA; Sutton EJ
    Eur Radiol; 2020 Feb; 30(2):756-766. PubMed ID: 31468162
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlation between voxel-wise enhancement parameters on DCE-MRI and pathological prognostic factors in invasive breast cancers.
    Trimboli RM; Codari M; Khouri Chalouhi K; Ioan I; Lo Bue G; Ottini A; Casolino D; Carbonaro LA; Sardanelli F
    Radiol Med; 2018 Feb; 123(2):91-97. PubMed ID: 28948442
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ultrafast dynamic contrast-enhanced breast MRI may generate prognostic imaging markers of breast cancer.
    Onishi N; Sadinski M; Hughes MC; Ko ES; Gibbs P; Gallagher KM; Fung MM; Hunt TJ; Martinez DF; Shukla-Dave A; Morris EA; Sutton EJ
    Breast Cancer Res; 2020 May; 22(1):58. PubMed ID: 32466799
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Maximum slope of ultrafast dynamic contrast-enhanced MRI of the breast: Comparisons with prognostic factors of breast cancer.
    Yamaguchi K; Nakazono T; Egashira R; Fukui S; Baba K; Hamamoto T; Irie H
    Jpn J Radiol; 2021 Mar; 39(3):246-253. PubMed ID: 33001328
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ultrafast Dynamic Contrast-Enhanced MRI Using Compressed Sensing: Associations of Early Kinetic Parameters With Prognostic Factors of Breast Cancer.
    Kim JJ; Kim JY; Hwangbo L; Suh HB; Son Y; Nickel MD; Grimm R
    AJR Am J Roentgenol; 2021 Jul; 217(1):56-63. PubMed ID: 33909465
    [No Abstract]   [Full Text] [Related]  

  • 7. Perfusion Parameters in Dynamic Contrast-enhanced MRI and Apparent Diffusion Coefficient Value in Diffusion-weighted MRI:: Association with Prognostic Factors in Breast Cancer.
    Lee HS; Kim SH; Kang BJ; Baek JE; Song BJ
    Acad Radiol; 2016 Apr; 23(4):446-56. PubMed ID: 26852247
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ultrafast Dynamic Contrast-Enhanced Breast MRI: Kinetic Curve Assessment Using Empirical Mathematical Model Validated with Histological Microvessel Density.
    Mori N; Abe H; Mugikura S; Takasawa C; Sato S; Miyashita M; Mori Y; Pineda FD; Karczmar GS; Tamura H; Takahashi S; Takase K
    Acad Radiol; 2019 Jul; 26(7):e141-e149. PubMed ID: 30269956
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlation of perfusion parameters on dynamic contrast-enhanced MRI with prognostic factors and subtypes of breast cancers.
    Koo HR; Cho N; Song IC; Kim H; Chang JM; Yi A; Yun BL; Moon WK
    J Magn Reson Imaging; 2012 Jul; 36(1):145-51. PubMed ID: 22392859
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantification of breast tumor heterogeneity for ER status, HER2 status, and TN molecular subtype evaluation on DCE-MRI.
    Chang RF; Chen HH; Chang YC; Huang CS; Chen JH; Lo CM
    Magn Reson Imaging; 2016 Jul; 34(6):809-819. PubMed ID: 26968141
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dynamic contrast-enhanced MRI kinetics of invasive breast cancer: a potential prognostic marker for radiation therapy.
    Loiselle CR; Eby PR; DeMartini WB; Peacock S; Bittner N; Lehman CD; Kim JN
    Int J Radiat Oncol Biol Phys; 2010 Apr; 76(5):1314-9. PubMed ID: 19604652
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characteristics of quantitative perfusion parameters on dynamic contrast-enhanced MRI in mammographically occult breast cancer.
    Ryu JK; Rhee SJ; Song JY; Cho SH; Jahng GH
    J Appl Clin Med Phys; 2016 Sep; 17(5):377-390. PubMed ID: 27685105
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Time-to-enhancement at ultrafast breast DCE-MRI: potential imaging biomarker of tumour aggressiveness.
    Shin SU; Cho N; Kim SY; Lee SH; Chang JM; Moon WK
    Eur Radiol; 2020 Jul; 30(7):4058-4068. PubMed ID: 32144456
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Breast MRI during lactation: effects on tumor conspicuity using dynamic contrast-enhanced (DCE) in comparison with diffusion tensor imaging (DTI) parametric maps.
    Nissan N; Allweis T; Menes T; Brodsky A; Paluch-Shimon S; Haas I; Golan O; Miller Y; Barlev H; Carmon E; Brodsky M; Anaby D; Lawson P; Halshtok-Neiman O; Shalmon A; Gotlieb M; Faermann R; Konen E; Sklair-Levy M
    Eur Radiol; 2020 Feb; 30(2):767-777. PubMed ID: 31529255
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Breast MRI contrast enhancement kinetics of normal parenchyma correlate with presence of breast cancer.
    Wu S; Berg WA; Zuley ML; Kurland BF; Jankowitz RC; Nishikawa R; Gur D; Sumkin JH
    Breast Cancer Res; 2016 Jul; 18(1):76. PubMed ID: 27449059
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Histogram analysis of quantitative pharmacokinetic parameters on DCE-MRI: correlations with prognostic factors and molecular subtypes in breast cancer.
    Nagasaka K; Satake H; Ishigaki S; Kawai H; Naganawa S
    Breast Cancer; 2019 Jan; 26(1):113-124. PubMed ID: 30069785
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predicting nodal status using dynamic contrast-enhanced magnetic resonance imaging in patients with locally advanced breast cancer undergoing neoadjuvant chemotherapy with and without sequential trastuzumab.
    Hsiang DJ; Yamamoto M; Mehta RS; Su MY; Baick CH; Lane KT; Butler JA
    Arch Surg; 2007 Sep; 142(9):855-61; discussion 860-1. PubMed ID: 17875840
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitative MRI morphology of invasive breast cancer: correlation with immunohistochemical biomarkers and subtypes.
    Bae MS; Seo M; Kim KG; Park IA; Moon WK
    Acta Radiol; 2015 Mar; 56(3):269-75. PubMed ID: 24558165
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The additional utility of ultrafast MRI on conventional DCE-MRI in evaluating preoperative MRI of breast cancer patients.
    Lee SJ; Ko KH; Jung HK; Koh JE; Park AY
    Eur J Radiol; 2020 Mar; 124():108841. PubMed ID: 31981877
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New parameters of ultrafast dynamic contrast-enhanced breast MRI using compressed sensing.
    Honda M; Kataoka M; Onishi N; Iima M; Ohashi A; Kanao S; Nickel MD; Toi M; Togashi K
    J Magn Reson Imaging; 2020 Jan; 51(1):164-174. PubMed ID: 31215107
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.